A generic medicine must adhere to the same batch specifications for identity, strength, purity, and quality, have the same use indications, and be equivalent in dosage form, strength, and administration technique. Drug manufacturers who want to commercialize a generic medication identical to (or bioequivalent to) the brand-name medication must submit an abbreviated new drug application (ANDA) to the FDA. The FDA examines the application to ensure that pharmaceutical companies have shown that the generic drug can be used instead of the brand-name drug it mimics. To know more, visit https://www.ikrispharmanetwork.com/generic-medication-supplier/.